Related content

Phase II study of liarozole in advanced non-small cell lung cancer

By O'Byrne K.J.   Han C.   Mitchell K.   Lane D.   Carmichael J.   Harris A.L.   Talbot D.C.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1463-1466

Elsevier

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Benk J.   Chemaissani A.   Scholtze J.   Lorenz C.   Niestroy A.   Dalhoff K.   Muller T.   Walter T.   Durk H.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 583-590

Elsevier

Access to resources Recommend Favorite

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

By Feliu J.   Martín G.   Castro J.   Sundlov A.   Rodriguez-Jaráiz A.   Casado E.   Lomas M.   Madroñal C.   Galán A.   Belda C.   Gonzalez-Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 527-531

Springer Publishing Company

Access to resources Recommend Favorite

Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer

By Chang Myung   Kim Kyoung   Jun Hyun   Kim Hyo   Yi Seong   Uhm Ji   Park Min   Lim Do   Ji Sang   Hwang In   Lee Jeeyun   Park Yeon   Ahn Jin   Ahn Myung-ju   Park Keunchil  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 917-924

Springer Publishing Company

Access to resources Recommend Favorite